'Watch and Wait' Feasible for Some Rectal Cancer Patients
TUESDAY, Nov. 3, 2020 -- A "watch-and-wait" (WW) strategy may be an option for carefully selected patients who achieve a complete response (CR) to neoadjuvant chemoradiation (nCRT) for rectal adenocarcinoma, according to a study published online Oct. 26 in the Journal of the American College of Surgeons.
Bryce W. Beard, M.D., from the Kaiser Permanente Bernard J. Tyson School of Medicine in Pasadena, California, and colleagues reviewed the medical records of patients treated with nCRT for nonmetastatic rectal cancer and compared outcomes for patients with CR to nCRT with and without surgery. The analysis included 465 patients who completed nCRT from January 2015 through February 2019.
The researchers report that 406 patients had a response assessment, of whom 23 percent had complete endoscopic response. Of these 95 patients, 53 underwent WW and 42 had surgery. During a median follow-up of 35 months, the three-year freedom from local regrowth was 85 percent in the WW group. Three-year overall survival was 100 versus 88 percent in the surgical versus WW group, while rectal cancer-specific survival was 100 versus 95 percent; freedom from non-regrowth recurrence was 92 versus 85 percent. In the six WW patients with local regrowth, five (83 percent) eventually developed distant recurrence.
"Careful evaluation to confirm clinical CR after nCRT is valuable in selecting patients for WW," the authors write.
© 2021 HealthDay. All rights reserved.
Posted: November 2020
Read this next
WEDNESDAY, Jan. 13, 2021 -- Several types of primary cancer are associated with an elevated risk for developing and dying from a subsequent primary cancer (SPC), according to a...
TUESDAY, Jan. 12, 2021 -- Overall cancer death rates have decreased continuously from 1991 to 2018, according to a study published online Jan. 12 in CA: A Cancer Journal for...
MONDAY, Jan. 11, 2021 -- Higher body mass index (BMI) is associated with a significantly increased risk for colorectal cancer (CRC) among men, whereas higher waist-to-hip ratio...
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.